SB 786 Requires health benefit plans to provide orally administered anticancer medications on a basis no less favorable than intravenously administered anticancer medications
1/14/2010 S First Read--SB 786-Rupp S121
1/19/2010 Second Read and Referred S Small Business, Insurance and Industry Committee S132
2/2/2010 Hearing Conducted S Small Business, Insurance and Industry Committee
3/2/2010 Voted Do Pass S Small Business, Insurance and Industry Committee
3/4/2010 Reported from S Small Business, Insurance and Industry Committee to Floor S519-520
3/17/2010 SS S offered & adopted (Rupp)--(4398S.02F) S583
3/17/2010 Perfected S583
3/17/2010 Reported Truly Perfected S Rules Committee S584
3/18/2010 Referred S Governmental Accountability and Fiscal Oversight Committee S589
4/1/2010 Voted Do Pass S Governmental Accountability and Fiscal Oversight Committee
4/1/2010 Reported from S Governmental Accountability and Fiscal Oversight Committee to Floor S747
4/6/2010 S Third Read and Passed S753-754 / H861
4/6/2010 H First Read H861
4/7/2010 H Second Read H868
4/8/2010 Referred H Special Standing Committee on General Laws Committee H910
4/12/2010 Re-referred H Health Care Policy Committee H920
4/14/2010 Hearing Conducted H Health Care Policy Committee

HyperLink